Fertility and Chronic Viral Reactivation (EBV, CMV, HHV-6): What We Know So Far

When fertility tests come back "normal" but conception or implantation still doesn't happen, patients are often left searching for answers beyond hormones and genetics. One emerging area of interest—especially in complex or immune-related infertility—is chronic viral reactivation.

Viruses such as Epstein-Barr virus (EBV), cytomegalovirus (CMV), and human herpesvirus 6 (HHV-6) are extremely common. Most people are exposed early in life and never feel sick. But in some individuals, these viruses may reactivate intermittently, triggering inflammation and immune dysregulation that could interfere with fertility and pregnancy.

What Is Chronic Viral Reactivation?

After the initial infection, herpes-family viruses remain latent in the body for life. In healthy immune systems, they usually stay inactive. However, certain stressors can allow them to reactivate, including:

• Chronic stress
• Autoimmune conditions
• Hormonal shifts
• Immune imbalance
• Inflammatory illness

Reactivation doesn't always cause obvious symptoms. Many people don't feel "sick" but may experience subtle issues like fatigue, brain fog, or inflammatory flares—or no symptoms at all.

Why Viral Reactivation May Matter for Fertility

Early pregnancy requires a finely tuned immune response. The immune system must tolerate an embryo (which is genetically different from the mother) while still defending against infection.

Chronic viral reactivation may disrupt this balance by:

• Increasing systemic inflammation
• Altering cytokine signaling
• Activating immune cells involved in implantation
• Contributing to endometrial immune dysfunction

In certain patients, this inflammatory environment may make implantation more difficult—or increase the risk of early pregnancy loss.

Epstein-Barr Virus (EBV) and Fertility

EBV is best known for causing mononucleosis, but over 90% of adults carry it. Research suggests that EBV reactivation may:

• Contribute to chronic inflammation
• Be associated with autoimmune activity
• Affect immune tolerance during implantation

While EBV is not considered a direct cause of infertility, immune-sensitive patients—especially those with unexplained implantation failure or recurrent pregnancy loss—may be more vulnerable to its effects.

CMV and HHV-6: Less Discussed, Potentially Relevant

CMV (Cytomegalovirus)

• Often asymptomatic in adults
• Known to impact pregnancy if acquired during pregnancy
• Chronic immune activation from CMV may contribute to inflammatory stress before conception

HHV-6

• Can integrate into human DNA in some individuals
• Has been detected in the endometrium in certain patients with unexplained infertility
• May influence local immune responses within the uterus

HHV-6 is an area of active research, particularly in patients with repeated implantation failure despite good-quality embryos.

Who Might Consider Viral Testing?

Viral reactivation testing is not routine for most fertility patients. However, it may be considered in more complex cases, such as:

• Recurrent implantation failure with euploid embryos
• Recurrent pregnancy loss without a clear cause
• Known autoimmune or inflammatory conditions
• IVF failure despite optimized protocols
• Persistent unexplained infertility

Testing typically looks at antibody patterns that suggest recent or ongoing immune activation rather than past exposure alone.

Can Viral Reactivation Be Treated?

Management depends on the patient's full clinical picture. Possible approaches may include:

• Addressing immune dysregulation
• Reducing systemic inflammation
• Supporting immune balance before embryo transfer
• Timing treatment to calm immune activation prior to conception or IVF

Importantly, treatment is highly individualized. The goal is not to eliminate viruses—which isn't possible—but to reduce their impact on the immune environment needed for implantation and early pregnancy.

What the Research Says—And What It Doesn't

It's important to be clear:

• Chronic viral reactivation is not a proven cause of infertility on its own
• Research is ongoing, and data is still evolving
• Not all patients with viral reactivation will have fertility issues

However, for a subset of patients—particularly those with immune-mediated infertility—viral activity may be one piece of a much larger puzzle.

A More Personalized Approach to Complex Infertility

Fertility is not just about eggs, sperm, and embryos. It's also about the environment in which implantation occurs.

For patients who've been told "everything looks normal" yet continue to experience failed transfers or losses, exploring immune and inflammatory contributors—including chronic viral reactivation—may help uncover answers that standard testing misses.

Final Thoughts

Chronic viral reactivation represents a growing area of interest in reproductive medicine, especially for patients with complex, unexplained, or immune-related infertility.

While it's not part of routine fertility care, for the right patient, evaluating immune triggers—including latent viral activity—can support a more thoughtful, individualized path toward pregnancy.

If traditional fertility treatments haven't worked as expected, it may be time to look deeper—not just at the embryo, but at the immune system supporting it.